Eaton Vance Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-545	Closed	-$32K	–	2094
2021 Q4	$32K	Hold	545	–	–	﹤0.01%	2264
2021 Q3	$32K	Buy	545 +272	+100%	+$16K	﹤0.01%	1584
2021 Q2	$24K	Sell	273 -12	-4%	-$1.06K	﹤0.01%	2382
2021 Q1	$23K	Buy	+285	New	+$23K	﹤0.01%	2018